4.5 Editorial Material

Criteria for Acceptable Dietary Intake Biomarkers

期刊

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-22-0180

关键词

-

资金

  1. National Heart, Lung, and Blood Institute, NIH, U.S. Department of Health and Human Services [HHSN268201600046C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C, HHSN271201600004C, 75N92021D00001]
  2. NCI [R01 CA119171]

向作者/读者索取更多资源

Dietary intake biomarkers can be used as substitutes for actual intake in disease association analyses, and can be developed through self-reported diet and participant measures for calibration. Criteria for biomarker development include considerations of error components, sensitivity, specificity, and stability of regression R-2 values.
Dietary intake biomarkers that can be written as actual intake, plus 'error' that is independent of actual intake and confounding factors can substitute for actual intake in disease association analyses. Also, such biomarkers can be used to develop calibration equations using self-reported diet and participant measures, and biomarker-calibrated intakes can be calculated in larger cohorts for use in disease association analyses. Criteria for biomarkers, and for biomarker-calibrated intakes, arise by working back from properties needed for valid disease association analyses. Accordingly, arguments for a potential biomarker are strengthened if error components are small relative to actual intakes, and important sources of reduced sensitivity or specificity are not apparent. Feeding study biomarker development can then involve regression of actual intake on putative biomarkers, with regression R-2 values playing a role in biomarker evaluation. In comparison, 'predictive' biomarker status, as argued in this issue by Freedman and colleagues for 24-hour urinary sucrose plus fructose as biomarker for total sugars, involves regression of potential biomarker on actual intake and other variables, with parameter stability across populations and limited within-person variability as criteria. The choice of criteria for biomarkers and for biomarker-calibrated intakes, is discussed here, in the context of total sugars intake.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据